How would you approach potentially tapering maintenance mycophenolate mofetil in a patient with a history of class IV LN that has been in remission for >5 years?
The case prompting the question is a female in her late teens who was diagnosed with Class IV LN at her prepubescent age and was treated with HCQ and CYC, and has been on MMF maintenance. Lupus is in remission clinically and serologically, and the patient is requesting to stop MMF and continue HCQ.
1 Answer
Mednet MemberInvited Expert
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)
Answered on
I would tell her, absolutely, and I'm sorry I did not consider this 2 years ago after being in remission for 3 years. ;-)
I then proceed to explain the options and make a shared decision-making process.
CHOICE 1 (my recommendation): A significant enough lupus nephritis patients are not in true patho...
Join for free or sign in to see the full answer